Abstract
The study aimed to assess whether factors related to cognitive performance were associated with the development of dementia. Additionally, the study aimed to establish whether cognitive performance at baseline or change in cognition between baseline and follow-up (five-year period) had a stronger association with whether an individual would fulfill a dementia criterion at follow-up. The data was collected from 2002 to 2011. Logistic regression was applied to the AGES-Reykjavik Study epidemiological data. The analysis, which builds upon previous data analyses of the same dataset, included 1,491 participants between the ages of 66 and 90. All those included were considered to have normal cognition at baseline; 8.2% (n = 123) of them fulfilled a dementia criterion at follow-up five years later. The study's results indicated that being high on cognitive reserve factors reduced the risk of developing dementia. Compared to other known dementia risk factors, cognitive reserve factors (education level, participation in leisure activities, and self-reported health) were more likely than others to have an association with dementia. Additionally, the study's findings showed that cognitive performance at baseline, rather than change in cognition between baseline and follow-up five years later, had a stronger association with dementia at the follow-up assessment. Together, these findings support the notion that promoting high cognitive reserve throughout the lifespan and reaching high cognitive performance is important in reducing dementia risk.
Similar content being viewed by others
References
World Health Organization. Global status report on the public health response to dementia. World Health Organization, Geneva, 2021. Accessed: Jul. 26, 2022. [Online]. Available: https://www.who.int/publications-detail-redirect/9789240033245.
Nichols E, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25. https://doi.org/10.1016/S2468-2667(21)00249-8.
Wolters FJ, et al. Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium. Neurology. 2020;95(5):e519–31. https://doi.org/10.1212/WNL.0000000000010022.
Walker KA, Power MC, Gottesman RF. Defining the relationship between hypertension, cognitive decline, and dementia: A review. Curr Hypertens Rep. 2017;19(3):24. https://doi.org/10.1007/s11906-017-0724-3.
Feinkohl I, Price JF, Strachan MWJ, Frier BM. The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors. Alzheimer’s Res Therapy. 2015;7(1):46. https://doi.org/10.1186/s13195-015-0130-5.
Abete P, et al. Cognitive impairment and cardiovascular diseases in the elderly. A heart–brain continuum hypothesis. Ageing Res Rev. 2014;18:41–52. https://doi.org/10.1016/j.arr.2014.07.003.
Nishtala A, et al. Atrial fibrillation and cognitive decline in the Framingham Heart Study. Heart Rhythm. 2018;15(2):166–72. https://doi.org/10.1016/j.hrthm.2017.09.036.
Zaninotto P, Batty GD, Allerhand M, Deary IJ. Cognitive function trajectories and their determinants in older people: 8 years of follow-up in the English Longitudinal Study of Ageing. J Epidemiol Community Health. 2018;72(8):685–94. https://doi.org/10.1136/jech-2017-210116.
Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2017;1863(5):1037–45. https://doi.org/10.1016/j.bbadis.2016.04.017.
Cunningham C, O’Sullivan R, Caserotti P, Tully MA. Consequences of physical inactivity in older adults: A systematic review of reviews and meta-analyses. Scand J Med Sci Sports. 2020;30(5):816–27. https://doi.org/10.1111/sms.13616.
Cooper R, et al. Objective measures of physical capability and subsequent health: a systematic review. Age Ageing. 2011;40(1):14–23. https://doi.org/10.1093/ageing/afq117.
Sindi S, et al. Sleep disturbances and dementia risk: A multicenter study. Alzheimer’s Dement. 2018;14(10):1235–42. https://doi.org/10.1016/j.jalz.2018.05.012.
Román GC, Jackson RE, Gadhia R, Román AN, Reis J. Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease. Revue Neurologique. 2019;175(10):724–41. https://doi.org/10.1016/j.neurol.2019.08.005.
Casanova R, Saldana S, Lutz MW, Plassman BL, Kuchibhatla M, Hayden KM. Investigating predictors of cognitive decline using machine learning. J Gerontol B Psychol Sci Soc Sci. 2020;75(4):733–42. https://doi.org/10.1093/geronb/gby054.
Antoniou M. The advantages of bilingualism debate. Annu Rev Linguist. 2019;5(1):395–415. https://doi.org/10.1146/annurev-linguistics-011718-011820.
Cheng S-T. Cognitive reserve and the prevention of dementia: The role of physical and cognitive activities. Curr Psychiatry Rep. 2016;18(9):85. https://doi.org/10.1007/s11920-016-0721-2.
Weiss J, Puterman E, Prather AA, Ware EB, Rehkopf DH. A data-driven prospective study of dementia among older adults in the United States. PLOS ONE. 2020;15(10):e0239994. https://doi.org/10.1371/journal.pone.0239994.
Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.
Ritchie SJ, et al. Predictors of ageing-related decline across multiple cognitive functions. Intelligence. 2016;59:115–26. https://doi.org/10.1016/j.intell.2016.08.007.
Salthouse TA. Correlates of cognitive change. J Exp Psychol Gen. 2014;143(3):1026–48. https://doi.org/10.1037/a0034847.
Seblova D, Berggren R, Lövdén M. Education and age-related decline in cognitive performance: Systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev. 2020;58:101005. https://doi.org/10.1016/j.arr.2019.101005.
Valsdóttir V, et al. Cognition and brain health among older adults in Iceland: the AGES-Reykjavik study. Geroscience. 2022;44(6):2785–800. https://doi.org/10.1007/s11357-022-00642-z.
Harris TB, et al. Age, gene/environment susceptibility–Reykjavik study: Multidisciplinary applied phenomics. Am J Epidemiol. 2007;165(9):1076–87. https://doi.org/10.1093/aje/kwk115.
McCarrey AC, An Y, Kitner-Triolo MH, Ferrucci L, Resnick SM. Sex differences in cognitive trajectories in clinically normal older adults. Psychol Aging. 2016;31(2):166–75. https://doi.org/10.1037/pag0000070.
Singh-Manoux A et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ;344. 2012. https://doi.org/10.1136/bmj.d7622.
Podsiadlo D, Richardson S. The timed ‘Up & Go’: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8. https://doi.org/10.1111/j.1532-5415.1991.tb01616.x.
Yesavage JA, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res. 1982;17(1):37–49. https://doi.org/10.1016/0022-3956(82)90033-4.
Delis DC, Kramer JH, Kaplan E, Ober BA. California verbal learning test manual - Adult version (Research edition). New York: The Psychological Corporation; 1987.
Wechsler DW. WAIS-III: Wechsler adult intelligence scale. Manual. New York: Psychological Corporation; 1955.
Salthouse TA, Babcock RL. Decomposing adult age differences in working memory. Dev Psychol. 1991;27(5):763–76.
Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643–62. https://doi.org/10.1037/h0054651.
Tabachnick BG, Fidell LS. Using multivariate statistics. 4th ed. Boston: Allyn and Bacon; 2001.
Johnson W, te Nijenhuis J, Bouchard TJ. Still just 1 g: Consistent results from five test batteries. Intelligence. 2008;36(1):81–95. https://doi.org/10.1016/j.intell.2007.06.001.
Saczynski JS, et al. Cognitive impairment: An increasingly important complication of type 2 diabetes: The age, gene/environment susceptibility–Reykjavik study. Am J Epidemiol. 2008;168(10):1132–9. https://doi.org/10.1093/aje/kwn228.
Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. https://doi.org/10.1016/0022-3956(75)90026-6.
Burnham KP, Anderson DR. Multimodel inference: Understanding AIC and BIC in model selection. Sociol Methods Res. 2004;33(2):261–304. https://doi.org/10.1177/0049124104268644.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological). 1995;57(1):289–300.
Scheltens P, et al. Alzheimer’s disease. Lancet. 2021;397(10284):1577–90. https://doi.org/10.1016/S0140-6736(20)32205-4.
Gaser C, Franke K, Klöppel S, Koutsouleris N, Sauer H. BrainAGE in mild cognitive impaired patients: predicting the conversion to Alzheimer’s disease. PLoS One. 2013;8(6):e67346. https://doi.org/10.1371/journal.pone.0067346.
World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. World Health Organization, Geneva, 2019. [Online]. Available: https://apps.who.int/iris/bitstream/handle/10665/312180/9789241550543-eng.pdf?sequence=1&isAllowed=y. Accessed 7 May 2021
Kivimäki M, et al. Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals. Alzheimer’s Dement. 2018;14(5):601–9. https://doi.org/10.1016/j.jalz.2017.09.016.
Pedditizi E, Peters R, Beckett N. The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age Ageing. 2016;45(1):14–21. https://doi.org/10.1093/ageing/afv151.
Singh-Manoux A, et al. Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study. Alzheimer’s Dement. 2018;14(2):178–86. https://doi.org/10.1016/j.jalz.2017.06.2637.
Stern Y, et al. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimer’s Dement. 2020;16(9):1305–11. https://doi.org/10.1016/j.jalz.2018.07.219.
Groot C, et al. Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease. Neurology. 2018;90(2):e149–56. https://doi.org/10.1212/WNL.0000000000004802.
Opdebeeck C, Martyr A, Clare L. Cognitive reserve and cognitive function in healthy older people: a meta-analysis. Aging Neuropsychol Cogn. 2016;23(1):40–60. https://doi.org/10.1080/13825585.2015.1041450.
Pettigrew C, Soldan A. Defining cognitive reserve and implications for cognitive aging. Curr Neurol Neurosci Rep. 2019;19(1):1–12. https://doi.org/10.1007/s11910-019-0917-z.
Lee DH et al. Effects of cognitive reserve in Alzheimer’s disease and cognitively unimpaired individuals. Front Aging Neurosci. 2022;13. https://doi.org/10.3389/fnagi.2021.784054.
Dekhtyar S, Marseglia A, Xu W, Darin-Mattsson A, Wang H-X, Fratiglioni L. Genetic risk of dementia mitigated by cognitive reserve: A cohort study. Ann Neurol. 2019;86(1):68–78. https://doi.org/10.1002/ana.25501.
Wang H-X, MacDonald SWS, Dekhtyar S, Fratiglioni L. Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: A community-based cohort study. PLOS Med. 2017;14(3):e1002251. https://doi.org/10.1371/journal.pmed.1002251.
Xu H, et al. Association of lifespan cognitive reserve indicator with dementia risk in the presence of brain pathologies. JAMA Neurol. 2019;76(10):1184–91. https://doi.org/10.1001/jamaneurol.2019.2455.
Formanek T, Kagstrom A, Winkler P, Cermakova P. Differences in cognitive performance and cognitive decline across European regions: a population-based prospective cohort study. Eur psychiatr. 2019;58:80–6. https://doi.org/10.1016/j.eurpsy.2019.03.001.
Soldan A, et al. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer’s disease. Neurobiol Aging. 2017;60:164–72. https://doi.org/10.1016/j.neurobiolaging.2017.09.002.
Jørgensen TSH, et al. Ageing populations in the Nordic countries: Mortality and longevity from 1990 to 2014. Scand J Public Health. 2019;47(6):611–7. https://doi.org/10.1177/1403494818780024.
Knudsen AK, et al. Life expectancy and disease burden in the Nordic countries: results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet Public Health. 2019;4(12):e658–69. https://doi.org/10.1016/S2468-2667(19)30224-5.
Jalovaara M, et al. Education, gender, and cohort fertility in the Nordic Countries. Eur J Population. 2019;35(3):563–86. https://doi.org/10.1007/s10680-018-9492-2.
Funding
This work was supported by The Foundation of St. Josef’s Hospital in cooperation with The Icelandic Gerontological Research Center, National University Hospital of Iceland. The AGES-Reykjavik Study was supported by the National Institutes of Health (Intramural Research Programs of the National Institute of Aging and the National Eye Institute, ZIAEY00401), National Institutes of Health contract number N01-AG-1–2100, the Icelandic Heart Association, and the Icelandic Parliament.
Additional grants were provided by Landspítali – University Hospital Research Fund, the Icelandic Gerontological Society, the Council on Aging in Iceland, Helga Jónsdóttir and Sigurliði Kristjánsson Memorial Fund and the Sustainability Institute and Forum (SIF) at Reykjavik University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that there is no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Valsdóttir, V., Magnúsdóttir, B.B., Gylfason, H.F. et al. Exposure factors associated with dementia among older adults in Iceland: the AGES-Reykjavik study. GeroScience 45, 1953–1965 (2023). https://doi.org/10.1007/s11357-023-00804-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-023-00804-7